Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)
Conditions: Non-Alcoholic Fatty Liver Disease; Liver Steatosis Interventions: Drug: Empagliflozin; Drug: Dulaglutide; Drug: Control Rx Sponsors: National and Kapodistrian University of Athens; Alexandra Hospital, Athens, Greece; Hippocration General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2023 Category: Research Source Type: clinical trials